Lipella Pharmaceuticals

(NASDAQ) LIPO

Current PriceN/A

Market CapN/A

Since IPO (2022)-100%

5 YearN/A

1 Year-97%

1 Month+237%

Lipella Pharmaceuticals Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$173.67K

Net Income (TTM)

-$5.33M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Jun 3, 2026

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Jun 3, 2026

LIPO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lipella Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jonathan Kaufman, PhD, MBA

Website

www.lipella.com

Headquarters

Pittsburgh, PA 15208, US

LIPO Financials

Key Financial Metrics (TTM)

Gross Margin

-20%

Operating Margin

-31%

Net Income Margin

-31%

Return on Equity

-2%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$3.08M

Operating Income

-$5.08M

EBITDA

-$5.01M

Operating Cash Flow

-$3.95M

Capital Expenditure

-$3.00

Free Cash Flow

-$3.95M

Cash & ST Invst.

$2.18M

Total Debt

$47.61K

Lipella Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$720.97K

+31.1%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$1.25M

+13.2%

EBITDA

-$1.27M

+12.7%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

$1.59M

+24.1%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$219.82K

N/A

Short Term Debt

$44.27K

-37.5%

Return on Assets

-2.27%

N/A

Return on Invested Capital

-3.17%

N/A

Free Cash Flow

-$2.36B

-360909.2%

Operating Cash Flow

-$2.36B

-360909.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.50-5.66%

GTBPGT Biopharma, Inc.

GTBPGT Biopharma, Inc.$0.44-8.51%

ARTLArtelo Biosciences, Inc.

ARTLArtelo Biosciences, Inc.$1.38-3.50%

NKGNNKGen Biotech, Inc. Common Stock

NKGNNKGen Biotech, Inc. Common Stock$0.06+0.00%

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.18-5.60%

VRAXVirax Biolabs Group Limited

VRAXVirax Biolabs Group Limited$0.21+7.27%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

Questions About LIPO

What is the current price of Lipella Pharmaceuticals?

Lipella Pharmaceuticals is trading at N/A per share.

What is the 52-week range for Lipella Pharmaceuticals?

Over the past 52 weeks, Lipella Pharmaceuticals has traded between N/A and N/A.

How much debt does Lipella Pharmaceuticals have?

As of the most recent reporting period, Lipella Pharmaceuticals reported total debt of $264.08K.

How much cash does Lipella Pharmaceuticals have on hand?

Lipella Pharmaceuticals reported $1.86M in cash and cash equivalents in its most recent financial results.

What is Lipella Pharmaceuticals’s dividend yield?

Lipella Pharmaceuticals does not currently have a dividend yield.

Lipella Pharmaceuticals

Lipella Pharmaceuticals Financials at a Glance

LIPO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lipella Pharmaceuticals

LIPO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lipella Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LIPO

What is the current price of Lipella Pharmaceuticals?

What is the 52-week range for Lipella Pharmaceuticals?

How much debt does Lipella Pharmaceuticals have?

How much cash does Lipella Pharmaceuticals have on hand?

What is Lipella Pharmaceuticals’s dividend yield?

Premium Investing Services